EVOK Evoke Pharma, Inc. gains 22% Sep 26, 2017

Posted By: Rajesh Srivastava - Tuesday, September 26, 2017

Share

& Comment

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development of drugs for the treatment of gastroenterological disorders and diseases. The company develops EVK-001, a metoclopramide nasal spray, which is in Phase III clinical trials for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Evoke Pharma, Inc. was founded in 2007 and is headquartered in Solana Beach, California. http://www.priceseries.com/trade/EVOK-Evoke-Pharma-Inc-stock-gains-22-percent-a-Trade-Record-by-priceSeries-2017090120170926.html

About Rajesh Srivastava

Techism is an online Publication that complies Bizarre, Odd, Strange, Out of box facts about the stuff going around in the world which you may find hard to believe and understand. The Main Purpose of this site is to bring reality with a taste of entertainment

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Copyright © priceSeries Daily Results™ is a registered trademark.

Designed by Templateism. Hosted on Blogger Platform.